COVID-19 Antibody Levels After Vaccines

Clinical trial NCT04944134 · COMPLETED

Trial details

NCT number: NCT04944134
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Study type: OBSERVATIONAL

Vaccine Preventable Disease

Start date: 2021-06-09
Primary completion: 2022-04-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.